Showing results (371-380 of 925) with videos related to
Sort By:
Pageof 93
Journal of the National Cancer Institute|February 19, 1992
Phase I study of streptozocin- and carmustine-sequenced administration in patients with advanced cancerK C Micetich, B Futscher, D Koch, et al.Clinical and Experimental Immunology|February 1, 1980
Chlorozotocin, an anti-tumour agent lacking bone marrow toxicity at therapeutic doses: effects on lymphocyte subpopulations in miceR I Fisher, G L Mandell, F Bostick, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1983
Neoplastic cells obtained from Hodgkin's disease are potent stimulators of human primary mixed lymphocyte culturesR I Fisher, F Bostick-Bruton, D N Sauder, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1984
Neoplastic cells obtained from Hodgkin's disease function as accessory cells for mitogen-induced human T cell proliferative responsesR I Fisher, S E Bates, F Bostick-Bruton, et al.Scientific Reports|December 29, 2019
TDP-43 aggregation inside micronuclei reveals a potential mechanism for protein inclusion formation in ALSCristian A Droppelmann, Danae Campos-Melo, Alexander J Moszczynski, et al.Neurosurgery|November 1, 1992
The Maudsley Mentation test: a method for extended monitoring of mental status after aneurysmal subarachnoid hemorrhageA J Strong, M A Wyke, I Daum, et al.Brain Research|December 3, 2008
Divergent patterns of cytosolic TDP-43 and neuronal progranulin expression following axotomy: implications for TDP-43 in the physiological response to neuronal injuryKatie Moisse, Kathryn Volkening, Cheryl Leystra-Lantz, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 16, 2026
Emerging strategies for interpreting variants of uncertain significance (VUS) in amyotrophic lateral sclerosisMinhal Ahmed, Kathryn Volkening, Crystal Mclellan, et al.Spinal Cord|June 1, 2011
Locomotor training using a robotic device in patients with subacute spinal cord injuryI Schwartz, A Sajina, M Neeb, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2004
Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: a nationwide studyGary H Lyman, David C Dale, Jonathan Friedberg, et al.Pageof 93